Diffusion is a biotechnology company developing therapies to enhance the oxygen delivery to hypoxic tissues for the treatment of hypoxic solid tumors.
Investment category: Biotechnology
Cargo Therapeutics, Inc.
CARGO is a biotechnology company advancing CAR‑T cell therapies for cancers.
CG Oncology, Inc.
CG Oncology is a biotechnology company developing potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
Symic Biomedical, Inc.
Symic is a biotechnology company developing extracellular matrix therapeutics.
Sorrento Therapeutics
Sorrento is a biotechnology company focused on developing treatments for cancer, autoimmune diseases, inflammation, and pain.
Sagimet Biosciences
Sagimet is a biotechnology company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways.
Alzheon, Inc.
Alzheon is a biotechnology company developing therapies for Alzheimer’s disease and other neurodegenerative disorders.
Otonomy, Inc.
Otonomy is a biotechnology company developing innovative therapeutics for diseases and disorders of the ear.
Solve Therapeutics
Solve is an antibody drug conjugate (ADC)-focused biotechnology company advancing the treatment of various cancer indications.
Inventiva
Inventiva is a biotechnology company developing oral small molecule therapies for fibrosis, oncology, and rare diseases.